跳至主要内容
临床试验/NL-OMON38497
NL-OMON38497已完成不适用

The Allergy Alert Test, a proof of concept study - AAT-POC

'Oréal0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Study subjects with PPD sensitization:
  • Males and females, 18-65 years of age;
  • Consecutively patch tested patients, who have shown positive reactions to PPD (+, ++ and +++) within the last 5 years included in the database of the department Dermatology;
  • Clinical relevance of the positive patch test reaction: self-declared past exposure to oxidation hair dyes and clinical manifestations compatible with contact sensitivity to hair dyes (documented in CRF). All patients will be required to provide information on the approximate shade (light, medium or dark) responsible for their reaction.
  • Healthy skin on the test site for at least 3 months on entering the study;
  • Legal competent;PPD-negative subject must meet all of the following criteria:
  • Consecutively patch tested patients, males and females, oxidative hair dye consumers, 18-65 years of age, who have shown negative reactions to PPD and to all other tested allergens with the exception of nickel (tests carried out 12 months to 3 weeks before inclusion into the study);
  • Sex and age-matched (within 5 years), whenever possible, to test subjects;
  • No history of adverse reactions to hair colouring products;
  • Healthy skin on the test site for at least 3 months;
  • Legal competent

排除标准

  • Hairdressers; current or past occupation
  • Current acute or widespread eczema at any site, any eczema on the test sites within the last 3 months before study;
  • Significant past medical history which in the opinion of the investigator can interfere with the study;
  • Febrile illness lasting more than 24 hours in the six days prior to each patch application;
  • Past or concomitant medication likely to affect the response to the test articles or confuse the results of the study (systemic treatment: corticosteroid or immunosuppressive 1 month prior and during the study);
  • Recent vaccination (less than 3 weeks prior to patch application);
  • Insulin-dependent diabetes;
  • Recent history of extensive sun exposure;
  • Deliberate exposure of the test sites to natural sunlight or artificial sources of UV light in the two weeks preceding the study, during the study, and during the two weeks following the study;
  • Participation in a diagnostic patch test during the six preceding weeks for PPD-positive subjects and during the three preceding weeks for PPD-negative subjects;
  • Pregnancy or breast feeding or active childwish

研究者

发起方
'Oréal

相似试验